LC
ROIV icon

Lindbrook Capital’s Roivant Sciences ROIV Stock Holding History

Lindbrook Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.65K Sell
461
-136
-23% -$1.47K ﹤0.01% 1981
2024
Q4 		$7.06K Sell
597
-202
-25% -$2.39K ﹤0.01% 1824
2024
Q3 		$9.22K Buy
799
+447
+127% +$5.09K ﹤0.01% 1716
2024
Q2 		$3.72K Buy
352
+78
+28% +$855 ﹤0.01% 2131
2024
Q1 		$2.89K Hold
274
– – ﹤0.01% 2113
2023
Q4 		$3.08K Buy
+274
New +$2.67K ﹤0.01% 2106
2023
Q2 		– Sell
-86
Closed -$635 – 2832
2023
Q1 		$635 Hold
86
– – ﹤0.01% 2560
2022
Q4 		$687 Buy
+86
New +$478 ﹤0.01% 2531

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Lindbrook Capital's ROIV Position: Q1 2025 in Review

Lindbrook Capital reduced its Roivant Sciences (ROIV) stake by 23% in Q1 2025, selling an estimated $1.47K and leaving 461 shares worth $4.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

Lindbrook Capital first reported a position in ROIV in Q4 2022 and has held it in 8 quarters since. The position peaked at $9.22K in Q3 2024. 313 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • Lindbrook Capital held 461 shares of Roivant Sciences worth $4.65K as of Q1 2025.
  • Lindbrook Capital sold 136 Roivant Sciences shares in Q1 2025, an estimated $1.47K.
  • Roivant Sciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1981 holding.
  • Lindbrook Capital first reported a position in Roivant Sciences in Q4 2022 and has held it in 8 quarters since.
  • Lindbrook Capital's Roivant Sciences position peaked at $9.22K in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.